GRITSTONE BIO INC (GRTS)
US39868T1051 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -144.89M | -138.49M | -119.69M | -75.08M | -105.31M | |||
| Depreciation Amortization | 7.53M | 7.59M | 6.56M | 6.35M | 6.64M | |||
| Change In Working Capital | -8.00M | -17.14M | -24.53M | -1.36M | -4.93M | |||
| Interest Paid | 2.83M | 2.42M | 650.00K | N/A | N/A | |||
| Other non cash items | 30.24M | 26.39M | 21.71M | 19.42M | 14.50M | |||
| OPERATING CASH FLOW | -115.13M | -121.65M | -115.95M | -50.68M | -89.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.15M | -4.57M | -5.87M | -5.46M | -3.52M | |||
| Other Investing Activity | 96.62M | 106.91M | -7.09M | -113.09M | 69.46M | |||
| INVESTING CASH FLOW | 93.47M | 102.34M | -12.96M | -118.55M | 65.95M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 9.70M | 19.68M | 18.90M | -60.00K | N/A | |||
| Stock Issued/Repurchased | 7.02M | 8.93M | 65.51M | 117.21M | 135.91M | |||
| Other Financing Activity | -626.00K | -3.49M | -1.31M | -8.39M | -100.00K | |||
| FINANCING CASH FLOW | 16.09M | 25.12M | 83.10M | 108.76M | 135.80M | |||
| CHANGE IN CASH | -5.56M | 5.81M | -45.81M | -60.47M | 112.65M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -115.13M | -121.65M | -115.95M | -50.68M | -89.10M | |||
| Capital Expenditure | -3.15M | -4.57M | -5.87M | -5.46M | -3.52M | |||
| FREE CASH FLOW | -118.27M | -126.22M | -121.82M | -56.14M | -92.62M | |||
All data in USD